These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 23429825)

  • 1. Depersonalization and derealization syndrome: report on a case study and pharmacological management.
    Salgado A; Oliveira L; Sierra-Siegert M; Salgado JV
    Braz J Psychiatry; 2012 Dec; 34(4):505-8. PubMed ID: 23429825
    [No Abstract]   [Full Text] [Related]  

  • 2. Venlafaxine in somatopsychic and autopsychic depersonalization.
    Preve M; Mula M; Cassano GB; Pini S
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Dec; 35(8):1808-9. PubMed ID: 21740948
    [No Abstract]   [Full Text] [Related]  

  • 3. A placebo-controlled, cross-over trial of lamotrigine in depersonalization disorder.
    Sierra M; Phillips ML; Ivin G; Krystal J; David AS
    J Psychopharmacol; 2003 Mar; 17(1):103-5. PubMed ID: 12680746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can venlafaxine in breast milk attenuate the norepinephrine and serotonin reuptake neonatal withdrawal syndrome.
    Koren G; Moretti M; Kapur B
    J Obstet Gynaecol Can; 2006 Apr; 28(4):299-301. PubMed ID: 16776907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Was the exacerbation of PTSD symptoms after high doses of venlafaxine due to the noradrenergic mechanism? A case report.
    da Rocha FF; Correa H
    Braz J Psychiatry; 2007 Mar; 29(1):94. PubMed ID: 17435946
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of obsessive-compulsive disorder with venlafaxine.
    Grossman R; Hollander E
    Am J Psychiatry; 1996 Apr; 153(4):576-7. PubMed ID: 8599411
    [No Abstract]   [Full Text] [Related]  

  • 7. Lamotrigine as an add-on treatment for depersonalization disorder: a retrospective study of 32 cases.
    Sierra M; Baker D; Medford N; Lawrence E; Patel M; Phillips ML; David AS
    Clin Neuropharmacol; 2006; 29(5):253-8. PubMed ID: 16960469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dosing by side effect threshold: two cases of panic disorder responsive to low-dose venlafaxine.
    Orenstein H; Raskind MA
    J Clin Psychiatry; 2010 Jan; 71(1):89-91. PubMed ID: 20129010
    [No Abstract]   [Full Text] [Related]  

  • 9. Comment on: Serotonin syndrome due to co-administration of linezolid and venlafaxine.
    Gillman PK
    J Antimicrob Chemother; 2004 Oct; 54(4):844-5. PubMed ID: 15317745
    [No Abstract]   [Full Text] [Related]  

  • 10. Venlafaxine, monoamine oxidase inhibitors, and the serotonin syndrome.
    Gitlin MJ
    J Clin Psychopharmacol; 1997 Feb; 17(1):66-7. PubMed ID: 9004070
    [No Abstract]   [Full Text] [Related]  

  • 11. Serotonin syndrome and rhabdomyolysis in venlafaxine poisoning: a case report.
    Hanekamp BB; Zijlstra JG; Tulleken JE; Ligtenberg JJ; van der Werf TS; Hofstra LS
    Neth J Med; 2005 Sep; 63(8):316-8. PubMed ID: 16186642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Lamotrigine in the treatment of resistant depersonalization disorder: A case report].
    Bout A; Berhili N; Benbrahim M; Aalouane R; Rammouz I
    Encephale; 2018 Feb; 44(1):85-87. PubMed ID: 28602528
    [No Abstract]   [Full Text] [Related]  

  • 13. Reduced testosterone level in a venlafaxine treated patient.
    Bell S; Shipman M
    Ann Clin Psychiatry; 2000 Sep; 12(3):171-3. PubMed ID: 10984008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Summer is the best time for Treatment of Resistant Depression in Adolescents (TORDIA): the importance of school in medication trials.
    Bostic JQ
    J Am Acad Child Adolesc Psychiatry; 2011 Nov; 50(11):1095-7. PubMed ID: 22023997
    [No Abstract]   [Full Text] [Related]  

  • 15. Venlafaxine-induced excessive yawning.
    Chen CH; Lu ML
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Feb; 33(1):156-7. PubMed ID: 19000733
    [No Abstract]   [Full Text] [Related]  

  • 16. Serotonin reuptake inhibitors in Raynaud's phenomenon.
    Jaffe IA
    Lancet; 1995 May; 345(8961):1378. PubMed ID: 7752794
    [No Abstract]   [Full Text] [Related]  

  • 17. A case of high-dose venlafaxine-related psychosis.
    Dennison EA; Raidoo BM; Cruz R; Raidoo D
    J Clin Psychopharmacol; 2013 Feb; 33(1):134-6. PubMed ID: 23288238
    [No Abstract]   [Full Text] [Related]  

  • 18. Serotonin syndrome secondary to phenelzine-venlafaxine interaction.
    Weiner LA; Smythe M; Cisek J
    Pharmacotherapy; 1998; 18(2):399-403. PubMed ID: 9545162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential physiological effects of a low dose and high doses of venlafaxine in major depression.
    Debonnel G; Saint-André E; Hébert C; de Montigny C; Lavoie N; Blier P
    Int J Neuropsychopharmacol; 2007 Feb; 10(1):51-61. PubMed ID: 16690006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evidence-based pharmacoanalytics of using venlafaxine in clinical medicine].
    Rachin AP; Sergeev AV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(5):68-70. PubMed ID: 19938277
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.